News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,896 Results
Type
Article (14423)
Company Profile (283)
Press Release (250190)
Section
Business (79699)
Career Advice (154)
Deals (13239)
Drug Delivery (34)
Drug Development (50841)
Employer Resources (31)
FDA (5744)
Job Trends (5145)
News (144970)
Policy (10124)
Tag
Academia (936)
Alliances (21734)
Alzheimer's disease (782)
Antibody-drug conjugate (ADC) (68)
Approvals (5729)
Artificial intelligence (84)
Bankruptcy (99)
Best Places to Work (4569)
Biotechnology (233)
Breast cancer (121)
Cancer (1025)
Cardiovascular disease (84)
Career advice (133)
CAR-T (84)
Cell therapy (244)
Clinical research (40693)
Collaboration (386)
Compensation (155)
COVID-19 (1087)
C-suite (100)
Cystic fibrosis (72)
Data (1069)
Diabetes (96)
Diagnostics (1234)
Drug discovery (64)
Earnings (29117)
Events (47619)
Executive appointments (310)
FDA (6172)
Funding (364)
Gene editing (71)
Gene therapy (190)
GLP-1 (330)
Government (1094)
Healthcare (6620)
Infectious disease (1129)
Inflammatory bowel disease (100)
IPO (7233)
Job creations (861)
Job search strategy (128)
Layoffs (195)
Legal (1400)
Lung cancer (151)
Manufacturing (93)
Medical device (2571)
Medtech (2572)
Mergers & acquisitions (6193)
Metabolic disorders (289)
Neuroscience (1073)
NextGen: Class of 2025 (2029)
Non-profit (862)
Northern California (1213)
Obesity (156)
Opinion (93)
Parkinson's disease (84)
Patents (74)
People (25290)
Phase I (14417)
Phase II (18928)
Phase III (11950)
Pipeline (453)
Postmarket research (854)
Preclinical (6021)
Radiopharmaceuticals (207)
Rare diseases (226)
Real estate (1416)
Regulatory (8418)
Research institute (952)
Series A (71)
Southern California (1095)
Startups (1976)
United States (9645)
Vaccines (200)
Weight loss (92)
Date
Today (90)
Last 7 days (270)
Last 30 days (1256)
Last 365 days (20549)
2025 (1207)
2024 (20693)
2023 (22553)
2022 (26988)
2021 (27994)
2020 (23535)
2019 (16349)
2018 (11824)
2017 (13847)
2016 (11929)
2015 (14454)
2014 (10469)
2013 (7557)
2012 (7588)
2011 (7673)
2010 (7465)
Location
Africa (147)
Asia (17119)
Australia (2892)
California (2771)
Canada (876)
China (253)
Colorado (104)
Connecticut (116)
Europe (37015)
Florida (311)
Georgia (83)
Illinois (175)
Indiana (67)
Maryland (365)
Massachusetts (2194)
Minnesota (112)
New Jersey (692)
New York (762)
North Carolina (446)
Northern California (1213)
Ohio (89)
Pennsylvania (534)
South America (211)
Southern California (1095)
Texas (315)
Washington State (267)
264,896 Results for "encoded therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Encoded Demonstrates Therapeutic Potential of a Vectorized miRNA-based Approach for Angelman Syndrome at the FAST Annual Global Science Summit
November 7, 2024
·
3 min read
Biotech Bay
Encoded Therapeutics Announces UK CTA Approval for Dravet Syndrome Gene Therapy Candidate ETX101
Encoded Therapeutics Inc. today announced the approval of its Clinical Trial Authorisation (CTA) application by the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency (MHRA) for the EXPEDITION Study of ETX101 as a potential treatment for children with SCN1A+ Dravet syndrome.
February 26, 2024
·
5 min read
Drug Development
Encoded Therapeutics Presents Preclinical Data Across its Gene Therapy Portfolio at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Encoded Therapeutics Inc., a biotechnology company developing genetic medicines for severe central nervous system disorders, highlights oral and poster presentations on the Company’s preclinical gene therapy programs and vector engineering platform at the 27th ASGCT Annual Meeting being held May 7 – 11, 2024 in Baltimore, MD.
May 7, 2024
·
5 min read
Biotech Bay
Encoded Therapeutics Provides Pipeline Updates From Its Vector Engineering Platform Ahead of Four Preclinical Presentations at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Encoded Therapeutics Provides Pipeline Updates From Its Vector Engineering Platform Ahead of Four Preclinical Presentations at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT).
April 23, 2024
·
5 min read
Biotech Beach
Encoded Therapeutics Announces US IND Clearance and Australian CTA Approval for Dravet Syndrome Gene Therapy Candidate ETX101
Encoded Therapeutics Inc., a biotechnology company focused on developing genetic medicines for severe central nervous system (CNS) disorders, today outlined the global development strategy for its lead gene therapy candidate, ETX101, for the treatment of SCN1A+ Dravet syndrome.
February 6, 2024
·
7 min read
Press Releases
Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery, Upcoming Webinar Hosted by HitGen and Xtalks
July 17, 2024
·
3 min read
Business
Aegis Life Receives Investment to Continue Development of DNA-Encoded Therapeutic Antibodies Against Infectious Diseases Using the Fusogenix PLV Platform
Aegis Life receives a program-related investment of $4.45M from the Bill & Melinda Gates Foundation.
March 19, 2024
·
6 min read
Drug Development
Virion Therapeutics Presents Promising Preclinical Cancer Data When Using a Novel Genetically Encoded Checkpoint Modifier-Based Immunotherapy
Virion Therapeutics, LLC presented data today of a genetically encoded checkpoint modifier-based immunotherapy, which enhances CD8+ T cell activation, in a fast-growing preclinical tumor model at the ESMO Target Anticancer Therapies Congress in Paris France.
March 6, 2023
·
4 min read
Biotech Bay
Encoded Therapeutics Addresses Common Source of Gene Therapy Toxicity While Achieving Precise Brain Expression in Non-Human Primates, Presented at the American Society of Gene and Cell Therapy 26th Annual Meeting
Encoded Therapeutics announced today the presentation of non-human primate (NHP) validation of the company’s technology to drive desired gene and protein expression patterns at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting.
May 19, 2023
·
2 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
1 of 26,490
Next
